Table 2.
Results and Outcome of Study
| Factor | Number (%) | CR (Complete Remission) | Median survival time(95%CI) | Last comparable survival time (probability) | Last calculated survival time (probability) | P-Value |
|---|---|---|---|---|---|---|
| Age | ||||||
| <30 | 40 (60.6) | 34 (85%) | - | 9 (705) | 13 (51.6%) | 0.008 |
| 30-60 | 18 (27.3) | 12 (66%) | - | 9 (50%) | - | |
| >60 | 8 (12.1) | 5 (62.5%) | 3 (0.0,7.0) | 9 (37.5%) | 13 (0%) | |
| Sex | ||||||
| Male | 53 (80.3) | 42 (79.24%) | 13 (8.1,17.9) | 11 (54.7%) | 16 (42.6%) | 0.650 |
| Female | 13 (19.7) | 9 (69.2%) | 11(53.8%) | |||
| WBC | ||||||
| ≤ 50000 | 51 (77.3) | 41 (80.39%) | - | 13 (58.8%) | 16 (52.3%) | 0.003 |
| >50000 | 15 (22.7) | 10 (66.6%) | 5 (0.0,10.0) | 13 (17.8%) | - | |
| PLT | ||||||
| ≤30000 | 26 (39.4) | 18 (69.2%) | 6 (1.0,11.0) | 15 (30.8%) | 16 (26.4%) - | 0.005 |
| >30000 | 40 (60.6) | 33 (82.5%) | - | 15 (57.0%) | ||
| LDH | ||||||
| ≤ 500 | 25 (37.9) | 19 (76%) | - | 15 (56.0%) | - | 0.243 |
| >500 | 45 (62.1) | 32 (78%) | 11 (6.0,16.0) | 15 (40.8%) | 16 (37.7%) |